Phase II evaluation of the efficacy and safety of trastuzumab plus pertuzumab therapy in patients with HER2-positive metastatic breast cancer that had progressed during trastuzumab treatment
J. Cortes, K. Gelmon, P. Fumoleau, A. Wardley, S. Verma, P.F. Conte, L. Gianni, S.J. Kirk, V. McNally, J. BaselgaVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70882-6
File:
PDF, 58 KB
english, 2008